Haemochromatosis gene mutations and risk of coronary heart disease: A west of Scotland coronary prevention study (WOSCOPS) substudy

Heart

Volumn 90, Issue 3, 2004, Pages 304-306

  Gunn, I R ^a   Maxwell, F K ^a   Gaffney, D ^b   McMahon, A D ^c   Packard, C J ^b  

^a WISHAW GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; PLACEBO; PRAVASTATIN;

ADULT; ARTICLE; BIOSAFETY; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE COURSE; FOLLOW UP; GENE FREQUENCY; GENE MUTATION; GENETICS; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MUTATION; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

EID: 1342301527     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.015149     Document Type: Article

References (21)

1. Sullivan JL. Iron and the genetics of cardiovascular disease. Circulation 1999;100:1260-3.
2. Salonen JT, Tuomainen T-P, Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. BMJ 200;320:1706-7.
3. Tuomainen TP, Salonen R, Nyyssonen K, et al. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4.
4. Meyers DG, Strickland D, Maloley PA, et al. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188-93.
5. Ascherio A, Willett WC. Are body iron stores related to the risk of coronary heart disease? N Engl J Med 1994;330:1152-4.
6. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
7. Miedzybrodzka Z, Loughlin S, Baty D, et al. Haemochromatosis mutations in North-East Scotland. Br J Haematol 1999;106:385-7.
8. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
9. Franco RF, Zago MA, Trip MD, et al. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease. Br J Haematol 1998;102:1172-5.
10. Battiloro E, Ombres D, Pascale E, et al. Haemochromatosis gene mutations and risk of coronary artery disease. Eur J Hum Genet 2000;8:389-92.
11. Calado RT, Franco RF, Pazin-Filio A, et al. HFE gene mutations in coronary atherothrombotic disease. Braz J Med Biol Res 2000;33:301-6.
12. Rossi E, McQuillan BM, Hung J, et al. Serum ferritin and C282Y mutation of the haemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population. Stroke 2000;31:3015-20.
13. Annichino-Bizzacchi JM, Saad ST, Arruda VR, et al. C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction. J Cardiovasc Risk 2000;7:37-40.
14. Hetet G, Elbaz A, Gariepy J, et al. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001;31:382-8.
15. Bozzini C, Girelli D, Yinazzi E, et al. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem 2002;48:622-8.
16. Tuomainen T-P, Kontula K, Nyyssonen K, et al. Increased risk of myocardial infarction in carriers of the haemochromatosis gene Cys282Tyr mutation. Circulation 1999;100:1274-9.
17. Roest M, Van der Schouw YT, de Valk B, et al. Heterozygosity for a hereditary haemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-73.
18. Rasmussen ML, Folsom AR, Catellier DJ, et al. A prospective study of coronary heart disease and the haemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2001;154:739-46.
19. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-7.
20. Danesh J, Appleby P. Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation 1999;99:852-4.
21. Sempos CT, Looker AC, Gillum RE, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National health and nutrition examination study. Ann Epidemiol 2000;10:441-8.